MedTrace Logo

Hypothermia's Impact on Pharmacology

NCT01560338 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 41

Last updated 2021-03-02

No results posted yet for this study

Summary

The purpose of the study will help us understand the complex interaction between hypothermia (cooling) and pharmacogenetics (how specific genes effect how drugs are handled), and their impact on how routinely given sedation drug are broken down and used by the body when given to children after cardiac arrest (when heart stops pumping blood) and are critically ill.

Conditions

  • Cardiac Arrest
  • Hypothermia

Sponsors & Collaborators

Principal Investigators

  • Athena F Zuppa, MD MSCE · Children's Hospital of Philadelphia

Eligibility

Max Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-03-31
Primary Completion
2018-01-31
Completion
2018-01-28

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01560338 on ClinicalTrials.gov